News & Updates
Filter by Specialty:
Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI
Free triiodothyronine (FT3) and free thyroxine (FT4) independently predict in-hospital cardiogenic shock (CS) incidence among patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI), reports a recent study.
Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI
13 Mar 2022Melatonin levels lower in prostate cancer patients
Patients with prostate cancer (PCa) have lower levels of melatonin than those without PCa, independent of urinary symptomatology or extension and aggressiveness of the tumour, a study has found.
Melatonin levels lower in prostate cancer patients
12 Mar 2022Record-high rise in alcohol-related hepatitis during pandemic a cause for alarm
Cases of severe alcohol-related hepatitis requiring inpatient management has dramatically increased during the COVID-19 pandemic, particularly in patients aged <40 years and in women, a study has found.
Record-high rise in alcohol-related hepatitis during pandemic a cause for alarm
12 Mar 2022Empagliflozin lowers blood pressure in T2D
Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.
Empagliflozin lowers blood pressure in T2D
12 Mar 2022Upadacitinib shows promise for long-term AD treatment
Upadacitinib with topical corticosteroids shows good long-term efficacy and safety in patients with moderate-to-severe atopic dermatitis (AD), reports a recent follow-up analysis to the AD Up study.